News

Jupiter Life Line Hospitals announced that the Board of Directors of the Company at its meeting held on 15 May 2026, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Net profit of Jupiter Life Line Hospitals rose 11.13% to Rs 50.21 crore in the quarter ended March 2026 as against Rs 45.18 crore during the previous quarter ended March 2025. Sales rose 15.20% to Rs 387.84 crore in the quarter ended March 2026 as against Rs 336.66 crore during the previous quarter ended March 2025.For the full year,net profit rose 0.42% to Rs 194.01 crore in the year ended March 2026 as against Rs 193.20 crore during the previous year ended March 2025. Sales rose 15.16% to Rs 1499.79 crore in the year ended March 2026 as against Rs 1302.40 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales387.84336.66 15 1499.791302.40 15 OPM %22.9923.68 -22.8923.04 - PBDT89.3080.98 10 352.97317.76 11 PBT66.0563.32 4 265.33260.68 2 NP50.2145.18 11 194.01193.20 0 Powered by Capital Market - Live News

Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 15 May 2026.

Net profit of Jupiter Life Line Hospitals declined 18.31% to Rs 42.55 crore in the quarter ended December 2025 as against Rs 52.09 crore during the previous quarter ended December 2024. Sales rose 9.78% to Rs 365.37 crore in the quarter ended December 2025 as against Rs 332.81 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales365.37332.81 10 OPM %22.8322.94 - PBDT85.0180.72 5 PBT63.3166.73 -5 NP42.5552.09 -18 Powered by Capital Market - Live News

Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live News